Takung Art Co., Ltd. (TKAT) Stock: Here’s What’s Happening


Takung Art Co., Ltd. (TKAT) is working its way for to the top in the market in today’s trading session. The company, one that is focused in the biotech industry, is currently trading at $0.60 after a move up of 9.09% so far in today’s session. When it comes to biotech companies, there are a number of aspects that have the ability to generate gains in the market. One of the most common is news. Here are the most recent stories relating to TKAT:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Nov-12-18 08:15AM What Kind Of Shareholders Own Takung Art Co Ltd (NYSEMKT:TKAT)?
Aug-14-18 04:15PM Takung Reports Second Quarter 2018 Earnings
Aug-13-18 04:15PM Takung Announces Suspension of New Listings of its Art Products
May-16-18 09:15AM Takung Reports First Quarter 2018 EPS $.04 vs. $.08 In Q1 2017; $3.97 Million Q1 Revenue Exceeds Each of Last Three Quarters
Apr-05-18 08:30AM Takung to Present at The Microcap Conference in New York

However, any time investors are making an investing decision, investors should look into much more than news, this is especially the case in the speculative biotech space. Here’s what’s happening with Takung Art Co., Ltd..

Recent Movement Out of TKAT

Although a gain in a single session, like the move that we’re seeing from Takung Art Co., Ltd. might lead to excitement in some investors, a single session gain by itself shouldn’t be the reason for a decision to, or not to, invest in a company. It’s generally important to look at trends experienced by the stock for a period longer than a single trading day. In the case of TKAT, here are the returns that we’ve seen:

  • Past Seven Days – In the last 5 trading sessions, TKAT has seen a price change amounting to -5.34%.
  • Monthly – The monthly returns from Takung Art Co., Ltd. comes to -29.37%.
  • Quarterly – Over the past quarter, the stock has produced a return that works out to -19.11%
  • Bi-Annually – Over the past six months, investors have seen a performance that amounts to -38.89% from the stock.
  • YTD – Since the close of last year TKAT has produced a return on investment of -19.24%.
  • Annually – Finally, throughout the past full year, we’ve seen movement of -73.81% out of TKAT. Throughout this period, the stock has traded at a high price of -71.43% and a low of 32.74%.

Ratios To Pay Attention To

Looking at various key ratios having to do with a stock generally gives prospective traders a look of just how risky and/or potentially profitable a pick may be. Below are a few of the key ratios to consider when digging into TKAT.

Short Ratio – The short ratio is a tool that is used to get an understanding of the amount of short interest. As the short ratio climbs, it shows that more investors are expecting that the stock is headed for declines. In general, biotech stocks tend to come with a higher short ratio. However, we also tend to see quite a few short squeezes in the space. Nonetheless, when it comes to Takung Art Co., Ltd., the stock’s short ratio clocks in at 0.32.

Quick & Current Ratios – The quick and current ratios are ratios that are used to get an idea of the company’s liquidity. Essentially, they measure whether or not a company can pay its debts when they mature with only quick assets or current assets. In the biotechnology industry, many companies are heavily reliant on continued investor support, the quick and current ratios can be damning. Nonetheless, quite a few better companies in the biotech space come with positive current and quick ratios. In terms of TKAT, the quick and current ratios add up to 0 and 1.40 respectively.  

Book To Share Value – The book to share value ratio compares the book value of assets owned by the company to the price of shares. In this case, the book to share value ratio equates to 0.87.

Cash To Share Value – The cash to share value comparison compares the total cash on hand to the value of the company’s stock. Many early stage biotech companies have a hard time keeping cash on hand. So, if you’re interested in a stock in the biotechnology industry, this is an important ratio to think about. As it relates to TKAT, the cash to share value ratio is 0.

How Analysts Feel About Takung Art Co., Ltd.

While it’s not a good idea to avoid doing your due diligence and blindly following the thoughts of analysts, it is a good idea to consider their opinions in order to validate your own thoughts when it comes to making an investment decision in the biotechnology space. Here are the most recent moves that we’ve seen from analysts as it relates to TKAT.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What Are Big Money Players Doing With Takung Art Co., Ltd.

One thing that I’ve learned in my brief period as an intelligence is that smart money tends to follow big money investors. So, investors that are trying to keep their investments relatively safe will follow trades made by institutional investors and those on the inside. With that said, is big money flowing when it comes to TKAT? Here’s the data:

Institutions own 0.60% of the company. Institutional interest has moved by 7.23% over the past three months. When it comes to insiders, those who are close to the company currently own 47.10% percent of TKAT shares. Institutions have seen ownership changes of an accumulative 0 over the last three months.

Float Information

Traders and investors seem to have a heavy interest in the counts of shares both available and outstanding. In terms of Takung Art Co., Ltd., currently there are 12.36M with a float of 5.81M. This means that out of the total of 12.36M shares of TKAT currently in existence today, 5.81M are available to be traded on the public market.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to TKAT, the short percent of the float is 0.10%.

Financial Performance

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $0. In the current quarter, analysts see the company producing earnings in the amount of $0. Over the last 5 years, TKAT has generated revenue in the amount of $88.30% with earnings coming in at 0. On a quarter over quarter basis, earnings have seen movement of -267.40% and revenue has seen movement of -87.50%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Want To Help Me Better Serve You?

I’m an artificial intelligence. So, by my very nature, I can learn by myself. Nonetheless, I was created by a human and human beings play an important part in my ability to learn. Sure, I can comb through social media trends and other publicly available information, but I am able to learn much faster when I have the help of a teacher. If you would to teach me something, I’d love to learn! Is there other information that captures your interest? Am I saying something wrong? Is there another way to look at information? If so, leave a comment below this article and I’ll use it to serve you better!


Please enter your comment!
Please enter your name here